Ashraf K., Tajeri S., Arnold C. S., Amanzougaghene N., Franetich J. F., Vantaux A., Soulard V., Bordessoulles M., Cazals G., Bousema T., Van Gemert G. J., Le Grand R., Dereuddre-Bosquet N., Barale J. C., Witkowski B., Snounou G., Duval Romain, Botte C. Y., Mazier D. (2021). Artemisinin-independent inhibitory activity of Artemisia sp. infusions against different Plasmodium stages including relapse-causing hypnozoites. Life Science Alliance, 5 (3), e202101237 [12 p.].
Titre du document
Artemisinin-independent inhibitory activity of Artemisia sp. infusions against different Plasmodium stages including relapse-causing hypnozoites
Année de publication
2021
Auteurs
Ashraf K., Tajeri S., Arnold C. S., Amanzougaghene N., Franetich J. F., Vantaux A., Soulard V., Bordessoulles M., Cazals G., Bousema T., Van Gemert G. J., Le Grand R., Dereuddre-Bosquet N., Barale J. C., Witkowski B., Snounou G., Duval Romain, Botte C. Y., Mazier D.
Source
Life Science Alliance, 2021,
5 (3), e202101237 [12 p.]
Artemisinin-based combination therapies (ACT) are the frontline treatments against malaria worldwide. Recently the use of traditional infusions from Artemisia annua (from which arte-misinin is obtained) or Artemisia afra (lacking artemisinin) has been controversially advocated. Such unregulated plant-based remedies are strongly discouraged as they might constitute sub-optimal therapies and promote drug resistance. Here, we conducted the first comparative study of the anti-malarial ef-fects of both plant infusions in vitro against the asexual erythrocytic stages of Plasmodium falciparum and the pre-erythrocytic (i.e., liver) stages of various Plasmodium species. Low concentrations of either infusion accounted for significant inhibitory activities across every parasite species and stage studied. We show that these antiplasmodial effects were essentially artemisinin-independent and were additionally monitored by observations of the parasite apicoplast and mitochondrion. In particular, the infusions significantly incapacitated sporozoites, and for Plasmodium vivaz and P. cynomolgi, disrupted the hypnozoites. This provides the first indication that compounds other than 8-aminoquinolines could be effective antimalarials against relapsing parasites. These observations advocate for further screening to uncover urgently needed novel antimalarial lead compounds.
Plan de classement
Santé : généralités [050]
;
Entomologie médicale / Parasitologie / Virologie [052]
;
Sciences du monde végétal [076]
Localisation
Fonds IRD [F B010083827]
Identifiant IRD
fdi:010083827
